Jesús
San Miguel Izquierdo
Consultor Investigador
![Foto de Jesús](/img/nophoto.png)
![Foto de Ibaraki Prefectural Central Hospital](/img/noimage_org.png)
Ibaraki Prefectural Central Hospital
Kasama, JapónIbaraki Prefectural Central Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2023
-
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis from the Randomized Phase II ELOQUENT-3 Trial
Journal of Clinical Oncology, Vol. 41, Núm. 3, pp. 568-578
2018
-
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
New England Journal of Medicine, Vol. 379, Núm. 19, pp. 1811-1822